GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » SenesTech Inc (NAS:SNES) » Definitions » Net Current Asset Value

SenesTech (SenesTech) Net Current Asset Value : $1.11 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is SenesTech Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

SenesTech's net current asset value per share for the quarter that ended in Dec. 2023 was $1.11.

The historical rank and industry rank for SenesTech's Net Current Asset Value or its related term are showing as below:

SNES' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.54   Med: 2.29   Max: 13.76
Current: 0.61

During the past 10 years, the highest Price-to-Net-Current-Asset-Value Ratio of SenesTech was 13.76. The lowest was 0.54. And the median was 2.29.

SNES's Price-to-Net-Current-Asset-Value is ranked better than
98.16% of 924 companies
in the Chemicals industry
Industry Median: 4.96 vs SNES: 0.61

SenesTech Net Current Asset Value Historical Data

The historical data trend for SenesTech's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenesTech Net Current Asset Value Chart

SenesTech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 191.85 126.16 180.26 68.42 1.11

SenesTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.42 16.58 9.31 8.06 1.11

Competitive Comparison of SenesTech's Net Current Asset Value

For the Specialty Chemicals subindustry, SenesTech's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SenesTech's Price-to-Net-Current-Asset-Value Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, SenesTech's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where SenesTech's Price-to-Net-Current-Asset-Value falls into.



SenesTech Net Current Asset Value Calculation

SenesTech's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(6.673-0.942-0-0)/5.14002
=1.11

SenesTech's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(6.673-0.942-0-0)/5.14002
=1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SenesTech  (NAS:SNES) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


SenesTech Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of SenesTech's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


SenesTech (SenesTech) Business Description

Traded in Other Exchanges
N/A
Address
23460 N 19th Avenue, Suite 110, Phoenix, AZ, USA, 85027
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets.
Executives
Joel Lee Fruendt director, officer: Chief Executive Officer C/O SENESTECH, INC., 23460 N. 19TH AVE., STE 110, PHOENIX AZ 85027
Grandinetti Phillip Nicholas Iii director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Kathleen Claire Kavanagh director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Jamie Bechtel Morrison director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Jacob Steven Leach director 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Delphine Francois Chiavarini director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Kenneth S Siegel director, officer: Chief Executive Officer 40 STARWOOD HOTELS & RESORTS, 111 WESTCHESTER AVE, WHITE PLAINS NY 10604
Nicole C Williams officer: Chief Strategy Officer 23460 N 19TH AVE SUITE 110, PHOENIX AZ 85027
Steven C. Krause officer: EVP, Sales and Marketing 23460 N. 19TH AVE STE 110, PHOENIX AZ 85027
Loretta Powers Mayer director, 10 percent owner, officer: CEO & Chief Scientific Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Cheryl Ann Dyer director, 10 percent owner, officer: Pres. & Chief Research Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Edward Albe officer: SVP of Commercialization 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 96004
Julia Ann Williams director C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Andrew Altman officer: Chief Operating Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Grover T Wickersham director, officer: Vice Chairman 430 CAMBRIDGE AVENUE, SUITE 100, PALO ALTO CA 94306